IL-1β activates the NF-κB pathway in tumour cells, inducing the secretion of monocyte chemotactic proteins (MCPs), which further recruit more myeloid cells, forming a vicious cycle of angiogenesis and immune suppression. Here, IL1B is linked to neoplasm.